We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Intellipharmaceutics Hit with Lawsuit for Allegedly Hyping Rexista
Intellipharmaceutics Hit with Lawsuit for Allegedly Hyping Rexista
Intellipharmaceutics artificially inflated its stock prices during the NDA process for its oxycodone product Rexista, a new class-action lawsuit claims.
